As of 2026-05-19, the Fair Value of Medicenna Therapeutics Corp (MDNA.TO) is -0.78 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.54 CAD, the upside of Medicenna Therapeutics Corp is -244.16%.
With the market price of 0.54 CAD and our fair value calculation, Medicenna Therapeutics Corp (MDNA.TO) is not a good investment. Investing in MDNA.TO stocks now will result in a potential loss of 244.16%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 5Y Avg | |
| Net income | -17.29 | -22.58 | -10.05 | -25.47 | -11.81 | -17.44 |
| YoY growth | -108.82% | -30.60% | 55.49% | -153.39% | 53.64% | -36.73% |
| Market Cap (mil) | 45.05 |
| P/E | |
| Forward P/E |
| EPS | -0.16 |
| Avg earnings growth rate | -36.73% |
| TTM earnings | -12.99 |